Company Performance Metrics
Robert Geho: Senior Vice President, Founder
SDG is a privately held bio-nanotechnology company with potential in medicine delivery systems and consumer products. The Company's patented systems have been used to develop novel oral delivery systems for insulin, interferon, and other protein-based therapies, cell-receptor targeting of a wide range of large and small molecule drugs and
diagnostics, and consumer products ranging from hair conditioners and styling agents to skin-adhering insect repellents and sunscreens. These technologies are ideal for application in cancer individualized therapy methods as cell receptor-targeted vehicles. SDG's technologies have been proven to be both safe and effective in a variety of disease categories, including diabetes and hepatitis, in over 400 human participants.
